Australia markets closed
  • ALL ORDS

    7,358.70
    +1.00 (+0.01%)
     
  • ASX 200

    7,114.50
    +1.70 (+0.02%)
     
  • AUD/USD

    0.6877
    -0.0038 (-0.55%)
     
  • OIL

    90.19
    -0.31 (-0.34%)
     
  • GOLD

    1,762.00
    -9.20 (-0.52%)
     
  • BTC-AUD

    31,094.78
    -3,007.00 (-8.82%)
     
  • CMC Crypto 200

    507.73
    -33.87 (-6.25%)
     
  • AUD/EUR

    0.6845
    -0.0001 (-0.01%)
     
  • AUD/NZD

    1.1130
    +0.0086 (+0.78%)
     
  • NZX 50

    11,684.81
    -129.53 (-1.10%)
     
  • NASDAQ

    13,238.10
    -267.89 (-1.98%)
     
  • FTSE

    7,550.37
    +8.52 (+0.11%)
     
  • Dow Jones

    33,719.29
    -279.75 (-0.82%)
     
  • DAX

    13,544.52
    -152.89 (-1.12%)
     
  • Hang Seng

    19,773.03
    +9.12 (+0.05%)
     
  • NIKKEI 225

    28,930.33
    -11.77 (-0.04%)
     

iCAD to Participate at the Imagine AI + Healthcare Investor Summit

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

NASHUA, N.H., Dec. 06, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey Stevens, President and incoming Chief Executive Officer, will present a corporate overview at Oppenheimer’s Imagine AI + Healthcare Investor Summit being hosted by Oppenheimer in partnership with the Alliance for AI in Healthcare (AAIH).

Oppenheimer’s Imagine AI + Healthcare Investor Summit
Date: Tuesday, December 7th
Time: 11:00 a.m. to 11:20 a.m. ET
Registration Link

About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com

Investor Relations:
Brian Ritchie, LifeSci Advisors
+ 1-212-915-2578
britchie@lifesciadvisors.com


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting